Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,660 across all filing types
Latest filing 2024-09-04 Annual Report
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Please find enclosed annual report for the financial year ended 31st March 2024 along-with notice of 39th Annual General Meeting.
Annual Report Classification · 100% confidence The document is a communication addressed to stock exchanges (NSE and BSE) dated 04.09.2024, announcing the availability of the Annual Report for the financial year 2023-24 along with the notice of the 39th Annual General Meeting. The text explicitly states 'Annual Report: 2023-24 along-with notice of 39th Annual General Meeting' and provides links to the Annual Report and AGM Notice on the company's website. The document includes detailed content typical of an Annual Report such as Directors' Report, Auditors' Report, Balance Sheet, Profit and Loss Statement, Cash Flow Statement, and Notes on Financial Statements. The length of the document (15,000 characters) and the presence of substantive financial data and management commentary confirm it is the full Annual Report, not just an announcement or a notice. Therefore, the document should be classified as an Annual Report (10-K). FY 2024
2024-09-04 English
Appointment of Mr. Sharad Jain, as an Independent Director with effect from 27-August-2024.
Board/Management Information Classification · 100% confidence The document is an official intimation to stock exchanges about the outcome of a Board of Directors meeting. It announces the appointment of a new Independent Director, Mr. Sharad Jain, including details about his term and profile. The document references compliance with SEBI Listing Regulations and includes an annexure with relevant details. There are no financial statements, earnings data, or report attachments. The content focuses solely on management/board changes. The document length is 3789 characters, which is relatively short and consistent with a management change announcement rather than a full report or presentation. Therefore, the document fits the category of Board/Management Information (MANG).
2024-08-27 English
Please find enclosed letter comprising outcome of board meeting held on 27-August-2024.
Board/Management Information Classification · 95% confidence The document is an official intimation to stock exchanges under SEBI Listing Regulations about the outcome of a Board of Directors meeting. It announces the appointment of a new Independent Director, Mr. Sharad Jain, including his term and brief profile. There is no financial data, earnings information, or report attached. The document is primarily about a change in the company's board of directors. Therefore, it fits the category of Board/Management Information (MANG). The document length is under 5,000 characters and does not indicate it is a report or announcement of a report publication, so it is not an RPA or RNS. Hence, the classification is MANG with high confidence.
2024-08-27 English
Appointment
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges regarding the outcome of a Board of Directors meeting. It announces the appointment of a new Independent Director, Mr. Sharad Jain, including details about his term and profile. The document references compliance with SEBI Listing Regulations and includes an annexure with relevant information about the appointment. There is no financial data, earnings information, or report attached or referenced as being published. The content is focused on management/board changes rather than financial results or other report types. Therefore, this document fits the category of Board/Management Information (MANG). The document length is under 5,000 characters and is a direct announcement, not a report publication or certification.
2024-08-27 English
Outcome of Board Meeting
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges regarding the outcome of a Board of Directors meeting. It announces the appointment of a new Independent Director, Mr. Sharad Jain, including details about his term and profile. The document references compliance with SEBI Listing Regulations and includes an annexure with relevant information about the appointment. There is no financial data, earnings information, or report attached or referenced as being published. The content focuses solely on management/board changes. Therefore, this document fits the category of Board/Management Information (MANG). The document length is under 5,000 characters and is not a report publication announcement or certification, so it is not RPA or RNS.
2024-08-27 English
Please find enclosed response from the company.
Regulatory Filings Classification · 95% confidence The document is a letter addressed to BSE Limited clarifying that the company has no pending announcements or unpublished price-sensitive information that could have impacted the share price. It references compliance with SEBI (LODR) Regulations, 2015, and confirms that recent price movements are market driven. The document is short (1636 characters) and serves as a regulatory clarification rather than a financial report or announcement of results. It does not contain financial data, management discussion, or any report content. It is primarily a regulatory compliance communication to the stock exchange. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-08-26 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.